Transcript
Diversity plays a crucial role in understanding genetics and enhancing treatment options across the full spectrum of human diversity globally. This biobank incorporates multiple aspects of diversity, including demographic components, a wide age range, representation of various diseases, and ethnic diversity.
A significant challenge in most biobanks worldwide is the underrepresentation of certain groups, despite these groups making up a substantial portion of the global population. Addressing this gap is essential for advancing personalized care and truly treating individuals. This requires delving deeply into a patient’s DNA to develop tailored treatments.
NashBio’s partners are committed to designing therapeutics that benefit patients globally. Their goal extends beyond developing drugs and treatments for specific regions, such as Europe. Instead, they strive for broad representation, ensuring no population is overlooked in the quest to prevent and treat human disease effectively.
